COVID-19 and gut immunomodulation

doi:10.3748/wjg.v27.i46.7925

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 46

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10327)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

665

WORD

110

HTML

6940

Figures (1-3)

384

Sum=8099

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

269

Download

580

Sum=849

Publishing Process of This Article

Item

Count

Browse

514

Download

865

Sum=1379

Dec 14, 2021 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Dec 14, 2021; 27(46): 7925-7942
Published online Dec 14, 2021. doi: 10.3748/wjg.v27.i46.7925

Full Size Figure Download Figure

Figure 3 Schematic diagram showing COVID-19 disease progression and correlation with alterations with gut microbiota. The progression of gut microbiome alteration and its association with clinical symptoms and gut dysbiosis is evident. Cartoon inspired by[10,62,85]. ACE2: Angiotensin-converting enzyme 2.

Citation: Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. COVID-19 and gut immunomodulation. World J Gastroenterol 2021; 27(46): 7925-7942
URL: https://www.wjgnet.com/1007-9327/full/v27/i46/7925.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i46.7925